LIF and neoplasm: Importantly, glycoprotein enrichment combined with targeted proteomics demonstrated that this signaling complex was significantly regulated in clinical PDAC tumor tissues, and LIF was further validated as a potential blood biomarker for early detection of PDAC by developing a highly sensitive digital ELISA.